Innovation Fails Because of Corporate Antibodies Innovation Excellence (blog) Innovation Fails Because of Corporate Antibodies Here's a big reason why open innovation efforts can fail: they are often killed by corporate antibodies resisting the changes brought by opening up to external partners. These antibodies can exist in ... |
